GGrantIndex
← Leaderboards

Alex Yee-Chen Huang

Case Western Reserve University

$8,501,439
Attributed
$11,230,150
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY201125
$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,230,150 · 9

By mechanism

T32$6,817,025 · 2
R01$2,966,375 · 2
R21$1,193,599 · 3
R03$160,000 · 1
P30$93,151 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorMediatingImmuneT-LymphocyteCellsInsightTissuesIn VivoMalignant NeoplasmsNovel TherapeuticsInvestigationMolecularFutureAffectSuccessAntigensMolecular TargetImmune ResponseLymphocyteImmunotherapyOrganImmune SystemAreaNeoplastic Cell

Grant awards (26)

Medical Scientist Training Program at Case Western Reserve University$1,632,261
T32 · FY2025 · GM · contact PI
MIZ1 Activation in Triple-negative Breast Cancer Racial Disparities$617,723
R01 · FY2025 · CA
Medical Scientist Training Program at Case Western Reserve University$60,545
T32 · FY2025 · GM · contact PI
Medical Scientist Training Program at Case Western Reserve University$1,678,206
T32 · FY2024 · GM · contact PI
MIZ1 Activation in Triple-negative Breast Cancer Racial Disparities$617,723
R01 · FY2024 · CA
Medical Scientist Training Program at Case Western Reserve University$59,936
T32 · FY2024 · GM · contact PI
Medical Scientist Training Program$1,673,974
T32 · FY2023 · GM · contact PI
Hematopoietic and Immune Cancer Biology Research Program$93,151
P30 · FY2023 · CA · contact PI
Medical Scientist Training Program$58,054
T32 · FY2023 · GM · contact PI
Medical Scientist Training Program$1,654,049
T32 · FY2022 · GM · contact PI
Characterizing a new antibody targeting growth-arrested breast cancer cells$80,000
R03 · FY2019 · CA · contact PI
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis$174,000
R21 · FY2018 · CA · contact PI
Characterizing a new antibody targeting growth-arrested breast cancer cells$80,000
R03 · FY2018 · CA · contact PI
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis$208,637
R21 · FY2017 · CA · contact PI
Cdk5 signaling in ICN1-induced T Cell Leukemogenesis$172,369
R21 · FY2016 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$325,775
R01 · FY2015 · CA · contact PI
Cdk5 signaling in ICN1-induced T Cell Leukemogenesis$206,843
R21 · FY2015 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$331,866
R01 · FY2014 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$15,864
R01 · FY2014 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$306,229
R01 · FY2013 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$56,206
R01 · FY2013 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$325,775
R01 · FY2012 · CA · contact PI
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo$235,500
R21 · FY2012 · AI · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$43,439
R01 · FY2012 · CA · contact PI
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming$325,775
R01 · FY2011 · CA · contact PI
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo$196,250
R21 · FY2011 · AI · contact PI